MME and myelodysplastic syndrome: The antigens CD10, CD11b, CD13, and CD16 may be abnormally expressed on PB neutrophils and may discriminate MDS patients from non‐MDS patients with sensitivities between 73%–93% and specificities of 90%–100% (Aires et al., 2018; Cherian et al., 2005a; Cherian et al., 2005b; Rashidi et al., 2012).